Combining the results of these two subgroup analyses, the wild guess that follicular GnRH agonist protocols may be considered as an alternative choice for PCOS patients with lower bLH/FSH and lower serum AMH levels was entertained in this study, as such protocols do not increase the risk of severe OHSS. Here, AMH is linked to polycystic ovary syndrome.